- Home
- TLPH vs SACH Comparison
TLPH vs SACH Comparison
Compare TLPH & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLPH | SACH |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | 27 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 38.4M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLPH | SACH |
|---|---|---|
| Price | $1.30 | $0.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 442.1K | 128.7K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | $145.00 |
| Revenue Next Year | N/A | $6.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $0.80 |
| 52 Week High | $1.57 | $1.45 |
Technical Indicators
Market Signals| Indicator | TLPH | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 31.20 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.46 | $1.12 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 26.32 | 12.57 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.